Skip to main content
Erschienen in: Die Diabetologie 3/2024

01.03.2024 | Lebensstilinterventionen | Journal Club

Einfluss der Remission des Typ-2-Diabetes auf das kardiovaskuläre und renale Risiko

verfasst von: Dr. med. Vojtech Pavlicek

Erschienen in: Die Diabetologie | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Auszug

Gregg EW, Chen H, Bancks MP et al for the Look AHEAD Research Group (2024) Impact of remission from type 2 diabetes on long—term health outcomes: findings from the Look AHEAD study. Diabetologia 67:459–469. …
Literatur
1.
Zurück zum Zitat Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308(23):2489–2496. https:// doi. org/ 10. 1001/ jama. 2012. 67929. Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308(23):2489–2496. https:// doi. org/ 10. 1001/ jama. 2012. 67929.
2.
Zurück zum Zitat >Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541–551. https:// doi. org/ 10. 1016/ S0140-6736(17) 33102‑1 >Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541–551. https:// doi. org/ 10. 1016/ S0140-6736(17) 33102‑1
3.
Zurück zum Zitat Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379(9833):2243–2251. https:// doi. org/ 10. 1016/ S0140-6736(12) 60525‑X Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379(9833):2243–2251. https:// doi. org/ 10. 1016/ S0140-6736(12) 60525‑X
4.
Zurück zum Zitat Chen Y, Zhang P, Wang J et al (2021) Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. Diabetologia 64(6):1279–1287. https:// doi. org/ 10. 1007/ s00125-021-05401‑x Chen Y, Zhang P, Wang J et al (2021) Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. Diabetologia 64(6):1279–1287. https:// doi. org/ 10. 1007/ s00125-021-05401‑x
5.
Zurück zum Zitat Hounkpatin H, Stuart B, Farmer A, Dambha-Miller H (2021) Association of type 2 diabetes remission and risk of cardiovascular disease in pre-defined subgroups. Endocrinol Diabetes Metab 4(3):e00280. https:// doi. org/ 10. 1002/ edm2. 280 Hounkpatin H, Stuart B, Farmer A, Dambha-Miller H (2021) Association of type 2 diabetes remission and risk of cardiovascular disease in pre-defined subgroups. Endocrinol Diabetes Metab 4(3):e00280. https:// doi. org/ 10. 1002/ edm2. 280
6.
Zurück zum Zitat Ryan DH, Espeland MA, Foster GD et al (2003) Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 24(5):610–628. https:// doi. org/ 10. 1016/ s0197-2456(03) 00064‑3 Ryan DH, Espeland MA, Foster GD et al (2003) Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 24(5):610–628. https:// doi. org/ 10. 1016/ s0197-2456(03) 00064‑3
Metadaten
Titel
Einfluss der Remission des Typ-2-Diabetes auf das kardiovaskuläre und renale Risiko
verfasst von
Dr. med. Vojtech Pavlicek
Publikationsdatum
01.03.2024
Verlag
Springer Medizin
Erschienen in
Die Diabetologie / Ausgabe 3/2024
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI
https://doi.org/10.1007/s11428-024-01166-0

Weitere Artikel der Ausgabe 3/2024

Die Diabetologie 3/2024 Zur Ausgabe

DDG Praxisempfehlungen

Adipositas und Diabetes

Einführung zum Thema

Adipositas

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.